- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 4.15M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $111.4M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.77M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.69M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.77M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.69M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $112.06M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $96.69M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $112.06M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $96.69M |
| Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.22M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.17M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $12.43M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $8.1M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$3.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$3.12 |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $2.68M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$3.8M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$3.91M |